Clinuvel Pharmaceuticals Limited, a biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, and li…
$5.10+1.59%
报价 2026-11-06
市值
$257.5M
EV
–
PE (TTM)
–
预期 PE
–
52 周区间距高点 -34.6%
$4.90$7.80
筛选结果
live estimateFilter✗ 高增长✗ Cheap✗ GARP
market cap below $300M floor
研究结论
还没有研究记录。先生成 L2 基本面报告（约 1–3 分钟），结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
同行业市值相近 · Medical - Pharmaceuticals| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| CUVLClinuvel Pharmaceuticals Ltd. | $257.5M | +1.6% | – | – | – | – | – | |
| LTGOLatigo Biotherapeutics Inc. | $757.9M | -3.2% | – | – | – | – | – | |
| CGEMCullinan Therapeutics, Inc. | $695.1M | +4.7% | +142.3% | 0% | – | – | – | |
| VCREVicore Pharma Holding AB | $293.8M | +3.9% | – | 81% | – | – | – | |
| HITIHigh Tide Inc. | $234.4M | -6.4% | – | 26.5% | – | – | – | |
| ETRAElectra Therapeutics Inc. | $165.5M | +6.1% | – | – | – | – | – | |
| LFMDLifeMD, Inc. | $114.4M | +3.5% | -5.1% | 85.9% | – | – | – | |
| TRXBTRex Bio Inc. | $110.5M | +2.1% | – | – | – | – | – | |
| RNTXRein Therapeutics Inc. | $52.9M | +0.3% | – | 0% | – | – | – | |
| 同行中位数 | – | – | +68.6% | 26.5% | – | – | – |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
暂无季度数据（首次研究运行后填充）。
研究材料
Filing 摘要
暂无 filing 摘要。
电话会纪要摘要
暂无纪要摘要。